Lineage Cell Therapeutics, Inc. Deferred Tax Liabilities, Net, Noncurrent
Lineage Cell Therapeutics, Inc. (LCTX) had Deferred Tax Liabilities, Net, Noncurrent of $6.34 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesNoncurrent · last filed 2019-11-12
- 2019-09-30: Deferred Tax Liabilities, Net, Noncurrent $6.34M.
- 2019-06-30: Deferred Tax Liabilities, Net, Noncurrent $7.33M.
- 2019-03-31: Deferred Tax Liabilities, Net, Noncurrent $8.58M.
- 2017-09-30: Deferred Tax Liabilities, Net, Noncurrent $4.84M.
| Period end | Deferred Tax Liabilities, Net, Noncurrent | Deferred Tax Liabilities, Net, Noncurrent as first filed |
|---|---|---|
| 2019-09-30 | $6.34M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $7.33M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $8.58M 10-Q · filed 2019-05-09 | |
| 2017-09-30 | $4.84M 10-Q · filed 2017-11-09 | |
| 2017-03-31 | $3.88M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-09 | |
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 | |
| 2015-09-30 | $1.12M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $2.07M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $3.34M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $4.51M 10-K · filed 2016-03-15 | $4.51M 10-K · filed 2015-03-11 |
| 2014-09-30 | $10.79M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $14.24M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $6.93M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $8.28M 10-K · filed 2015-03-11 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |